Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Home-withdrawal and Mindfulness for MOH during COVID-19
NCT04410536Phase 4Completed
- Sponsor
- Carlo Besta Neurological Institute
- Start
- Jun 2020
- Primary completion
- Dec 2021
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial, sponsored by Carlo Besta Neurological Institute. Primary endpoint: Drop out rates at 12 months. Started Jun 2020; status: completed.
Beyond the preview
Go deeper on NCT04410536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04410536.